Figure Markets Announces Global Launch, 8% Yield Opportunity
The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.Read More
Recent Posts
Recent Comments
No comments to show.
Archives
Recent Post
